← Open Payments lookup

ANDREW GENAW: Open Payments

NPI 1285898528 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$597 in 28 payments from 14 companies in 2025. Trend: 2023 $207 · 2024 $608 · 2025 $597

Food & beverage: $597
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$97
UCB, Inc.3$67
ABBVIE INC.3$63
Lilly USA, LLC3$58
PFIZER INC.2$47
Aimmune Therapeutics, Inc.2$44
Otsuka America Pharmaceutical, Inc.2$40
Novo Nordisk Inc2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
E.R. Squibb & Sons, L.L.C.1$26

Products named: INGREZZA, ELIQUIS, Briviact, REXULTI, ZENPEP, Ozempic, CAPLYTA, MOUNJARO.

Industry payments across WI — which companies pay providers there.